All ETFs

PHLCX

ETF

PHLCX · UNKNOWN · 43 holdings

$9.47

▲ $0.16 (1.72%)

Day Range

—

52-Week Range

—

Volume

—

Open —

50D / 200D Avg

—

50D / 200D Avg

—

About PHLCX

No description available for this ETF.

Fund Details

Expense Ratio: —
Inception Date: —
Prev. Close: $9.31
Exchange: UNKNOWN
Currency: USD
Holdings As Of: Apr 10, 2026
Tracked Holdings: 88.4%
HHI Score: 423.79
Top Sector: Healthcare (77.956435%)

Performance

Moderate (23.4%) ↗ Recovering

▲ 2.36%

▼ -0.10%

▼ -2.56%

▼ -23.70%

YTD

▼ -2.46%

▼ -13.36%

▼ -43.04%

Positive 1W (+2.36%) after negative 1M (-0.1%) — trend may be reversing

Price History

Concentration Risk

49.69% Moderately Concentrated

Diversified Concentrated

The top 10 holdings represent 49.69% of the fund. A moderate concentration level — the fund balances top holdings with broader diversification.

Top Holdings Today

Weighted by position size

LLY

▲ 0.57%

VRTX

▼ -0.07%

ARGX

▲ 1.31%

NBIX

▼ -1.57%

AZN

▲ 0.61%

TMO

▲ 0.16%

NVO

▼ -0.74%

ALNY

▼ -1.85%

UNH

▲ 0.09%

▼ -2.07%

Weighted avg. of top holdings ▼ -0.08%

Sector Allocation

Healthcare

77.96%

Financial Services

2.68%

Manufacturing

0.19%

Top 10 Holdings

49.69% of fund

LLY Eli Lilly & Co

14.59%

VRTX Vertex Pharmaceuticals Inc

4.95%

ARGX Argenx SE

4.84%

NBIX Neurocrine Biosciences Inc

4.78%

AZN AstraZeneca PLC

4.64%

TMO Thermo Fisher Scientific Inc

3.57%

NVO Novo Nordisk A/S

3.49%

ALNY Alnylam Pharmaceuticals Inc

3.14%

UNH UnitedHealth Group Inc

2.85%

EW Edwards Lifesciences Corp

2.84%

Other positions

10.89%

All Holdings (43)

Top 10: 49.69% of fund

#	Ticker	Name	Weight	Shares	Market Value
1	LLY	Eli Lilly & Co	14.59%	265,302	195.71 M
2	VRTX	Vertex Pharmaceuticals Inc	4.95%	150,218	66.40 M
3	ARGX	Argenx SE	4.84%	113,310	64.96 M
4	NBIX	Neurocrine Biosciences Inc	4.78%	520,854	64.08 M
5	AZN	AstraZeneca PLC	4.64%	854,038	62.20 M
6	TMO	Thermo Fisher Scientific Inc	3.57%	118,988	47.93 M
7	NVO	Novo Nordisk A/S	3.49%	655,469	46.87 M
8	ALNY	Alnylam Pharmaceuticals Inc	3.14%	138,476	42.17 M
9	UNH	UnitedHealth Group Inc	2.85%	126,565	38.21 M
10	EW	Edwards Lifesciences Corp	2.84%	487,173	38.11 M
11	VRNA	Verona Pharma PLC	2.81%	464,168	37.69 M
12	UCB	UCB SA	2.68%	197,591	35.95 M
13	LONN	Lonza Group AG	2.55%	49,206	34.14 M
14	ABT	Abbott Laboratories	2.34%	234,734	31.36 M
15	ARQT	Arcutis Biotherapeutics Inc	2.21%	2.27 M	29.59 M
16	INSM	Insmed Inc	2.09%	401,806	28.02 M
17	CVS	CVS Health Corp	2.04%	428,269	27.43 M
18	DHR	Danaher Corp	1.99%	140,737	26.73 M
19	GEHC	GE HealthCare Technologies Inc	1.88%	358,242	25.27 M
20	DXCM	Dexcom Inc	1.59%	249,266	21.39 M
21	CRNX	Crinetics Pharmaceuticals Inc	1.54%	675,458	20.61 M
22	RVTY	Revvity Inc	1.48%	219,203	19.82 M
23	BPMC	Blueprint Medicines Corp	1.38%	183,012	18.55 M
24	TARS	Tarsus Pharmaceuticals Inc	1.23%	382,765	16.44 M
25	STMN	Straumann Holding AG	1.10%	114,927	14.78 M
26	TNDM	Tandem Diabetes Care Inc	1.08%	732,318	14.51 M
27	NAMS	Newamsterdam Pharma Co NV	1.05%	777,280	14.08 M
28	PCVX	Vaxcyte Inc	0.94%	388,884	12.63 M
29	XENE	Xenon Pharmaceuticals Inc	0.88%	407,083	11.74 M
30	STVN	Stevanato Group SpA	0.87%	523,209	11.62 M
31	APLS	Apellis Pharmaceuticals Inc	0.87%	686,301	11.62 M
32	MLYS	Mineralys Therapeutics Inc	0.86%	738,891	11.51 M
33	ISRG	Intuitive Surgical Inc	0.62%	15,086	8.33 M
34	KYMR	Kymera Therapeutics Inc	0.61%	274,195	8.13 M
35	SION	Sionna Therapeutics Inc	0.57%	553,942	7.58 M
36	MTSR	Metsera Inc	0.44%	221,101	5.91 M
37	TVTX	Travere Therapeutics Inc	0.44%	393,263	5.91 M
38	VERA	Vera Therapeutics Inc	0.35%	247,916	4.70 M
39	A	Agilent Technologies Inc	0.31%	36,977	4.14 M
40	APGE	Apogee Therapeutics Inc	0.31%	112,496	4.12 M
41	CABA	Cabaletta Bio Inc	0.19%	1.38 M	2.58 M
42	KMTS	Kestra Medical Technologies Lt	0.08%	48,217	1.09 M
43	BBNX	Beta Bionics Inc	0.06%	43,415	748,474.6

Showing top 10 of 43 holdings · Listed: 89.11% · 10.89% in other positions

Related ETFs